Evidence map›Paper›PMID 41193529›Full record

ArticleScientific reports2025

Machine learning models predict mortality risk in diabetic neuropathy patients using MIMIC-IV data.

Yanyi Huang, Wei Mo, Yang Liu, Shuanglin Wang, Yanping Zeng, Pingping Jiang, He Wang, Jianlu Bi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yanyi Huang *The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wei Mo *The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yang LiuThe Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Shuanglin WangThe Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yanping ZengThe Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Pingping JiangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China.
He WangThe Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jianlu BiThe Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China. bijianlu1984@163.com.

Funding

National Natural Science Foundation of China 82104910University - Hospital Joint Fund Project of Guangzhou University of Chinese Medicine GZYSE2024G09
6 · The paper itself

Abstract

We aimed to construct and validate interpretable models for predicting mortality risk using machine learning (ML) methods to identify the risk factors associated with mortality in patients with diabetic neuropathy (DN). We selected patients from the US-based critical care database (Medical Information Mart for Intensive Care (MIMIC-IV)). Independent risk factors for in-hospital death were screened using Least Absolute Shrinkage and Selection Operator (LASSO). Subsequently, we constructed mortality risk prediction models utilizing random forest (RF), extreme gradient boosting (XGBoost), support vector machine (SVM), and logistic regression (LR). Finally, we comprehensively assessed and interpreted the best-performing ML model using SHapley Additive exPlanations (SHAP) analysis. The final study enrolled 1,313 patients with DN, randomly split into training (1,050, 80%) and validation sets (263, 20%). The RF model demonstrated superior performance, with an area under the curve (AUC) of 0.780 for the validation set. According to the feature importance result, red blood cell distribution width (RDW)_mean was identified as the most influential feature. This study demonstrated the potential of leveraging ML as a viable approach for predicting mortality risk in patients with DN. An interpretable ML model exhibited strong performance that could support clinical decision-making and enhance patient prognosis to some extent.

Indexed as

Diabetic NeuropathiesMachine LearningAgedDatabases, FactualFemaleHospital MortalityHumansLogistic ModelsMaleMiddle AgedPrognosisRisk AssessmentRisk FactorsSupport Vector MachineDiabetic neuropathiesMachine learning algorithmsMIMIC-IV databasePredictive learning model

Identifiers

PMID41193529
PMCPMC12589392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.